The Initial Public Offer (IPO) of pharmaceutical company Medistep Healthcare Limited will open on Friday, August 8, 2025. The issue will remain open for subscription till Tuesday, August 12, 2025. The share will be listed on NSE SME platform on Monday, August 18, 2025.
Fast Track Finsec Private Limited is the Lead Manager of the issue while Cameo Corporate Services Limited is the Registrar to the issue.
The company, which is in the business of manufacturing sanitary pads & energy powder; and trading of a diverse range of pharmaceutical products, Nutraceutical products, Intimate Products and surgical products through distribution network, has fixed a price of INR 43 per equity share for its maiden issue.
Through its IPO, the company hopes to raise INR 16.09 crore. The company will utilise the proceeds for funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility, working capital requirements and general corporate purpose.
A total of 37,44,000 equity shares of face value INR 10 each is being offered under the IPO. Investors will have to invest in the lot size of INR 3000 equity share. A minimum of 17.79 lakh equity shares is earmarked for retail investors while a maximum of 17.76 lakh equity shares is earmarked for noninstitutional investors and 1.89 lakh equity shares for market makers.
Mr. Girdhari Lal Prajapati, Managing Director, Medistep Healthcare said: “The proceeds from the IPO will strategically support our expansion efforts and reinforce our footprint in both domestic and international markets. Our diversified and growing product portfolio—including sanitary pads, energy powders, pharmaceuticals, nutraceuticals, surgical supplies, and intimate care products—positions us well to capitalize on the rising global & domestic demand for health and hygiene solutions. With increasing consumer awareness and a rapidly evolving pharmaceutical market, we are confident in our ability to scale operations, drive market penetration, and deliver sustained value to our stakeholders.”
Established in 2023, the company has a strong distribution network, offers low-cost products, has a strong retail and distributors’ networks. It recorded revenue from operations of INR 4965.48 lakhs in FY25, up from INR 3907.19 lakhs in FY24. The company’s EBITDA grew from INR 454.2 lakh in FY24 to INR 560 lakh in FY25. The company’s PAT grew from INR 332.76 lakh in FY24 to INR 414.42 lakh in FY25.
Post-listing, the market cap of the company will be INR 61.10 crore.